Results 131 to 140 of about 624,431 (182)
Light chain deposition disease masquerading as hypophosphatemic osteomalacia: a case report. [PDF]
Chen J +6 more
europepmc +1 more source
Urate-lowering therapy modifies associations between urinary urate and kidney outcome. [PDF]
Takata T +6 more
europepmc +1 more source
Tubulointerstitial nephritis uveitis syndrome with Fanconi syndrome: Two case reports and literature review. [PDF]
Lin J, Sun J.
europepmc +1 more source
Clinical and genetic analysis of <i>MOCOS</i> gene-related hypouricemia. [PDF]
Peng H +7 more
europepmc +1 more source
Low Serum Uric Acid as an Independent Predictor of Mortality and Poor Prognosis: A Retrospective Cohort Study. [PDF]
Şahin Sİ +6 more
europepmc +1 more source
Mutational Analysis of Idiopathic Renal Hypouricemia in Korea
Idiopathic renal hypouricemia is a hereditary disease characterized by abnormally high renal uric acid clearance. Most patients are clinically silent, but acute renal failure (ARF), urolithiasis, or hematuria may develop. A defect in the SLC22A12 gene, which encodes the renal uric acid transporter, URAT1, is the known major cause of this disorder.
Il Soo Ha, Hae Il Cheong, Joo Hoon Lee
exaly +4 more sources
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Molecular Genetics and Metabolism, 2006
Hereditary renal hypouricemia (HRH) is an inborn error of renal membrane transport specific for uric acid, resulting in increased renal urate clearance associated with hypouricemia. Apparently in most HRH patients, the disorder is caused by loss of function mutations in the gene SLC22A12 coding for human urate transporter 1 (hURAT1), shown to control ...
Oded Sperling, O Sperling
exaly +3 more sources
Hereditary renal hypouricemia (HRH) is an inborn error of renal membrane transport specific for uric acid, resulting in increased renal urate clearance associated with hypouricemia. Apparently in most HRH patients, the disorder is caused by loss of function mutations in the gene SLC22A12 coding for human urate transporter 1 (hURAT1), shown to control ...
Oded Sperling, O Sperling
exaly +3 more sources
Cholangiocarcinoma and Severe Renal Hypouricemia: A Study of the Renal Mechanisms
American Journal of Kidney Diseases, 1991Hypouricemia in malignant neoplasms is rarely reported. We present a previously unreported case of cholangiocarcinoma associated with severe persistent hypouricemia (serum uric acid levels ranged from 0.07 to 0.08 mmol/L [1.16 to 1.40 mg/100 mL], and increased urate clearance (50.90 to 57.33 mL/min v a mean value in 20 normal subjects of 9.75 +/- 1.65 ...
G Tsapas
exaly +3 more sources
Archives of Internal Medicine, 1987
• In diabetes, the serum uric acid level is low due to increased urate clearance; however, its mechanism remains unknown. We examined seven maturity-onset diabetic patients with rarely reported hypouricemia due to renal tubular abnormality to better understand the renal handling of urate by the diabetic kidney.
M, Shichiri, H, Iwamoto, T, Shiigai
openaire +3 more sources
• In diabetes, the serum uric acid level is low due to increased urate clearance; however, its mechanism remains unknown. We examined seven maturity-onset diabetic patients with rarely reported hypouricemia due to renal tubular abnormality to better understand the renal handling of urate by the diabetic kidney.
M, Shichiri, H, Iwamoto, T, Shiigai
openaire +3 more sources

